Bidirectional Glenn shunt surgery using lepirudin anticoagulation in an infant with heparin-induced thrombocytopenia with thrombosis

Anesthesia and Analgesia

Volumn 101, Issue 1, 2005, Pages 74-76

  Iannoli, Ellen D ^a,b   Eaton, Michael P ^a   Shapiro, Janine R ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b Box 604 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN; LEPIRUDIN;

ANTICOAGULATION; ARTICLE; CARDIOPULMONARY BYPASS; CARDIOVASCULAR SURGERY; CASE REPORT; CONGENITAL HEART DISEASE; HEMATOLOGICAL PARAMETERS; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; HYPOPLASTIC LEFT HEART SYNDROME; INFANT; MALE; PARTIAL THROMBOPLASTIN TIME; PEDIATRIC SURGERY; PRIORITY JOURNAL; TREATMENT OUTCOME;

ANTICOAGULANTS; BLOOD COAGULATION TESTS; CARDIAC SURGICAL PROCEDURES; HEART CATHETERIZATION; HEMODYNAMIC PROCESSES; HEPARIN; HIRUDINS; HUMANS; HYPOPLASTIC LEFT HEART SYNDROME; INFANT; MALE; MONITORING, INTRAOPERATIVE; PARTIAL THROMBOPLASTIN TIME; RECOMBINANT PROTEINS; THROMBOCYTOPENIA; THROMBOSIS;

EID: 20744452041     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000153019.15297.0B     Document Type: Article

References (17)

1. Malherbe S, Tsui BC, Stobart K, Koller J. Argatroban as anticoagulant in cardiopulmonary bypass in an infant and attempted reversal with recombinant activated factor VII. Anesthesiology 2004;100:443-5.
2. Saxon BR, Black MD, Edgell D, et al. Pediatric heparin-induced thrombocytopenia: management with Danaparoid (orgaran). Ann Thorac Surg 1999;68:1076-8.
3. Despotis GJ, Hogue CW, Saleem R, et al. The relationship between hirudin and activated clotting time: implications for patients with heparin-induced thrombocytopenia undergoing cardiac surgery. Anesth Analg 2001;93:28-32.
4. Greinacher A. Treatment of heparin-induced thrombocytopenia. Thromb Haemost 1999;82:457-67.
5. Koster A, Hansen R, Kuppe H, et al. Recombinant hirudin as an alternative for anticoagulation during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II: a 1-year experience in 57 patients. J Cardiothorac Vasc Anesth 2000;14:243-8.
6. Nuttall GA, Oliver WC Jr, Santrach PJ, et al. Patients with a history of type II heparin-induced thrombocytopenia with thrombosis requiring cardiac surgery with cardiopulmonary bypass: a prospective observadonal case series. Anesth Analg 2003;96:344-50.
7. Despotis GJ, Joist JH. Anticoagulation and anticoagulation reversal with cardiac surgery involving cardiopulmonary bypass: an update. J Cardiothorac Vasc Anesth 1999;13(4 Suppl 1): 18-29.
8. Koster A, Meyer O, Fischer T, et al. One-year experience with the platelet glycoprotein IIb/IIIa antagonist tirofiban and heparin during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II. J Thorac Cardiovasc Surg 2001;122:1254-5.
9. Furukawa K, Ohteki H, Hirahara K, et al. The use of argatroban as an anticoagulant for cardiopulmonary bypass in cardiac operations. J Thorac Cardiovasc Surg 2001;122:1255-6.
10. Warkentin TE, Greinacher A. Heparin-induced thrombocytopenia and cardiac surgery Ann Thorac Surg 2003;76:2121-31.
11. Klenner AF, Lubenow N, Raschke R, Greinacher A. Heparin-induced thrombocytopenia in children: 12 new cases and review of the literature. Thromb Haemost 2004;91:719-24.
12. Deitcher SR, Topoulos AP, Bartholomew JR, Kichuk-Chrisant MR. Lepirudin anticoagulation for heparin-induced thrombocytopenia. J Pediatr 2002;140:264-6.
13. McDonald SB, Kattapurum BM, Saleem R, et al. Monitoring hirudin anticoagulation in two patients undergoing cardiac surgery with a plasma-modified act method. Anesthesiology 2002; 97:509-12.
14. Potzsch B, Madlener K, Seelig C, et al. Monitoring of r-hirudin anticoagulation during cardiopulmonary bypass-assessment of the whole blood ecarin clotting time. Thromb Haemost 1997;77: 920-5.
15. Latham P, Revelis AF, Joshi GP, et al. Use of recombinant hirudin in patients with heparin-induced thrombocytopenia with thrombosis requiring cardiopulmonary bypass. Anesthesiology 2000;92:263-6.
16. Leo A, Winteroll S. Laboratory diagnosis of heparin-induced thrombocytopenia and monitoring of alternative anticoagulants. Clin Diagn Lab Immunol 2003;10:731-40.
17. Koster A, Loebe M, Hansen R, et al. A quick assay for monitoring recombinant hirudin during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II: adaptation of the ecarin clotting time to the act II device. J Thorac Cardiovasc Surg 2000;119:1278-83.